CitroTech Inc.
CITRNYSEMaterials · Chemicals & Allied Products · WY · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4M | $800,000 | $520,645 | $62,732 | $0 | — |
| Operating income | −$16.5M | −$5.3M | −$10.1M | −$2.9M | −$37,909 | −$109,355 |
| Net income | −$36.8M | −$6.9M | −$10.1M | −$2.9M | −$94,973 | −$109,355 |
| Total assets | $14.2M | $5.5M | $5.3M | $4.4M | $81 | $0 |
| Total liabilities | $2.9M | $2.2M | $1.7M | $1.1M | $383,090 | $9,355 |
| Equity | $11.3M | $3.3M | $3.6M | $3.3M | −$52,859 | −$9,355 |
| EPS (diluted) | $-2.96 | $-0.82 | $-0.10 | $0.00 | $0.00 | $0.00 |
| Shares out. | 52.4M | 36.3M | 93.9M | 22.9M | 22.9M | 22.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −692.7%
- Net margin
- −1546.9%
- Return on equity
- −327.1%
- Return on assets
- −259.7%
- Return on capital (ROCE)
- −137.3%
- Liabilities / assets
- 20.6%
- Debt / equity
- 0.26×
- Book value / share
- $0.22
- Revenue growth (YoY)
- 197.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -27.36distress
- Accruals / assets
- −218.3%clean
- Beneish M-Score
- -11.63normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 196,364 | 4.4 | -9.0% |
| Apr 30, 2026 | 215,753 | 3.7 | +7.0% |
| Apr 15, 2026 | 201,700 | 4.9 | +17.0% |
| Mar 31, 2026 | 172,370 | 1.3 | +620.0% |
| Mar 13, 2026 | 23,940 | 1.0 | +28.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity saleJun 1, 2026
- Entered a material agreementApr 21, 2026
- Entered a material agreement · Director / officer changeApr 3, 2026
- Amended charter or bylaws · Other material eventJan 28, 2026
- Entered a material agreement · Unregistered equity sale · Director / officer changeOct 21, 2025
- Entered a material agreement · Unregistered equity sale · Director / officer changeOct 7, 2025
- Modified shareholder rights · Amended charter or bylawsSep 10, 2025
- Director / officer changeApr 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4Jun 1, 2026
- 3Jun 1, 2026
- 4Jun 1, 2026
- SCHEDULE 13D/AJun 1, 2026
- 8-KFORM 8-KJun 1, 2026
- 10-QFORM 10-Q FOR MAR 2026May 15, 2026
- DEF 14CFORM DEF14CMay 5, 2026
- 4Apr 30, 2026
- SCHEDULE 13D/AApr 30, 2026
- 4Apr 24, 2026
- 8-KFORM 8-KApr 21, 2026
- 4Apr 17, 2026
- PRE 14CPRELIMINARY INFORMATION STATEMENTApr 15, 2026
- 424B3PROSPECTUSApr 15, 2026
- EFFECTApr 14, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.